Time Point Is Important for Effects of Syngeneic Bone Marrow Transplantation for Type 1 Diabetes in Mice

Transplantation Proceedings

Volumn 41, Issue 5, 2009, Pages 1801-1807

  Wen, Y ^a   Ouyang, J ^a   Li, W ^a   Chen, J ^a   Liu, Y ^a   Meng, L ^a   Zhang, H ^a   Zhou, X ^b  

^a THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

^b JINLING HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR FOXP3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BONE MARROW TRANSPLANTATION; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; EXPERIMENTAL MOUSE; HISTOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; STREPTOZOCIN DIABETES;

ANIMALS; BLOOD GLUCOSE; BONE MARROW TRANSPLANTATION; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; FLOW CYTOMETRY; FOLLOW-UP STUDIES; INSULIN; MALE; MICE; MICE, INBRED C57BL; PANCREAS; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, ISOGENEIC;

EID: 67249159743     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.01.101     Document Type: Article

References (27)

1. Birk O.S., and Cohen I.R. T-cell autoimmunity in type 1 diabetes mellitus. Curr Opin Immunol 5 (1993) 903
2. Eastman R.C., Siebert C.W., Harris M., et al. Clinical review 51: implications of the Diabetes Control and Complications Trial. J Clin Endocrinol Metab 77 (1993) 1105
3. Brodnicki T.C., Quirk F., and Morahan G. A susceptibility allele from a non-diabetes-prone mouse strain accelerates diabetes in NOD congenic mice. Diabetes 52 (2003) 218
4. Georgiou H.M., Slattery R.M., and Charlton B. Bone marrow transplantation prevents autoimmune diabetes in nonobese diabetic mice. Transplant Proc 25 (1993) 2896
5. Li H., Inverardi L., and Ricordi C. Chimerism-induced remission of overt diabetes in nonobese diabetic mice. Transplant Proc 31 (1999) 640
6. Leykin I., Nikolic B., and Sykes M. Mixed bone marrow chimerism as a treatment for autoimmune diabetes. Transplant Proc 33 (2001) 120
7. Zorina T.D., Subbotin V.M., Bertera S., et al. Recovery of the endogenous beta cell function in the NOD model of autoimmune diabetes. Stem Cells 21 (2003) 377
8. Elkin G., Prigozhina T.B., and Slavin S. Prevention of diabetes in nonobese diabetic mice by nonmyeloablative allogeneic bone marrow transplantation. Exp Hematol 32 (2004) 579
9. Kang E.M., Zickler P.P., Burns S., et al. Hematopoietic stem cell transplantation prevents diabetes in NOD mice but does not contribute to significant islet cell regeneration once disease is established. Exp Hematol 33 (2005) 699
10. Muller A., Schott-Ohly P., Dohle C., et al. Differential regulation of Th1-type and Th2-type cytokine profiles in pancreatic islets of C57BL/6 and BALB/c mice by multiple low doses of streptozotocin. Immunobiology 205 (2002) 35
11. Like A., and Rossini A. Streptozocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 193 (1976) 415
12. Banerjee M., Kumar A., and Bhonde R.R. Reversal of experimental diabetes by multiple bone marrow transplantation. Biochem Biophys Res Commun 328 (2005) 318
13. Urbán V.S., Kiss J., Kovacs J., et al. Mesenchymal stem cells cooperate with bone marrow cells in therapy of diabetes. Stem Cells 26 (2008) 244
14. Burt R.K., Slavin S., Burns W.H., et al. Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure?. Blood 99 (2002) 768
15. Herrmann M.M., Gaertner S., Stadelmann C., et al. Tolerance induction by bone marrow transplantation in a multiple sclerosis model. Blood 106 (2005) 1875
16. Voltarelli J.C., Couri C.E., Stracieri A.B., et al. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 297 (2007) 1568
17. Wen Y., Ouyang J., Yang R., et al. Reversal of new-onset type 1 diabetes in mice by syngeneic bone marrow transplantation. Biochem Biophys Res Commun 374 (2008) 282
18. Paik S.G., Fleischer N., and Shin S.I. Insulin-dependent diabetes mellitus induced by subdiabetogenic doses of streptozotocin: obligatory role of cell-mediated autoimmune processes. Proc Natl Acad Sci U S A 77 (1980) 6129
19. Shevach E.M. CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2 (2002) 389
20. Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22 (2004) 531
21. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 6 (2005) 345
22. de Kleer I., Vastert B., Klein M., et al. Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network. Blood 107 (2006) 1696
23. Roord S.T., de Jager W., Boon L., et al. Autologous bone marrow transplantation in autoimmune arthritis restores immune homeostasis through CD4+CD25+Foxp3+ regulatory T cells. Blood 111 (2008) 5233
24. Zhan H., Sinclair J., Adams S., et al. Immune reconstitution and recovery of FOXP3 (forkhead box P3)-expressing T cells after transplantation for IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked) syndrome. Pediatrics 121 (2008) e998
25. Jaeckel E., Mpofu N., Saal N., et al. Role of regulatory T cells for the treatment of type 1 diabetes mellitus. Horm Metab Res 40 (2008) 126
26. Tiittanen M., Huupponen J.T., Knip M., et al. Insulin treatment in patients with type 1 diabetes induces upregulation of regulatory T-cell markers in peripheral blood mononuclear cells stimulated with insulin in vitro. Diabetes 55 (2006) 3446
27. Seidel M.G., Ernst U., Printz D., et al. Expression of the putatively regulatory T-cell marker FOXP3 by CD4(+)CD25+ T cells after pediatric hematopoietic stem cell transplantation. Haematologica 91 (2006) 566